Nano-scale liquid chromatography/mass spectrometry and on-the-fly orthogonal array optimization for quantification of therapeutic monoclonal antibodies and the application in preclinical analysis.
about
Reproducible ion-current-based approach for 24-plex comparison of the tissue proteomes of hibernating versus normal myocardium in swine modelsQuantitative proteomics in cardiovascular research: global and targeted strategiesToward sensitive and accurate analysis of antibody biotherapeutics by liquid chromatography coupled with mass spectrometry.Impact of Sample Matrix on Accuracy of Peptide Quantification: Assessment of Calibrator and Internal Standard Selection and Method Validation.Nano-liquid chromatography in pharmaceutical and biomedical research.A critical review of microextraction by packed sorbent as a sample preparation approach in drug bioanalysis.Assessments of antibody biodistribution.Antibody-free workflows for protein quantification by LC-MS/MS.Quantitative MS analysis of therapeutic mAbs and their glycosylation for pharmacokinetics study.Effects of calibration approaches on the accuracy for LC-MS targeted quantification of therapeutic protein.Qualitative and quantitative characterization of protein biotherapeutics with liquid chromatography mass spectrometry.A multiplexed hybrid LC-MS/MS pharmacokinetic assay to measure two co-administered monoclonal antibodies in a clinical study.Sensitive, High-Throughput, and Robust Trapping-Micro-LC-MS Strategy for the Quantification of Biomarkers and Antibody Biotherapeutics.Practical considerations in enhancing LC-MS sensitivity for therapeutic protein bioanalysis.Quantitative LC/ESI-SRM/MS of antibody biopharmaceuticals: use of a homologous antibody as an internal standard and three-step method development.3-(4-Hydroxyphenyl)propionic acid: the forgotten detection substrate for ligand-binding assay-based bioanalysis.
P2860
Q33588975-9D1C753D-BEE5-4470-86DF-07782C0FC320Q34156082-846CBA2F-282C-4399-9B93-C2BE6B334F53Q34359998-DE430804-F064-4057-9049-26FE2CBAFFB1Q36756623-7D85434A-68DF-4201-958B-5C81A9656298Q38098981-95645A4F-A6B0-4FBD-B803-43E4D6ED5364Q38112479-C03B618F-C5BB-4CBB-BF83-EBE0F142D834Q38364460-9CB615DF-226A-43E9-AEF9-479349135726Q38420122-53D61BE7-4595-4059-9E88-62EBCC877CA1Q38628086-ABD8C85F-665F-40B7-93DE-5EA8DCDF8A67Q38699577-37BF8F9D-B9AB-4617-9AA9-4AD6AC32BD29Q38812885-335AD650-9589-48C8-A776-A32C2BE500FEQ46146057-0D453FCA-5385-4FC9-86A7-864B48B0DADDQ47256369-D7A2B178-27DB-4465-9DF0-A0415B478A9CQ47732300-C21D13CE-A8D1-4389-86A5-6AF1B2BF3C79Q48721182-53508E7A-507D-405C-AB57-3046C5F139B7Q51181142-2FDECA4D-5BE0-4CBE-BCC5-F624075632AB
P2860
Nano-scale liquid chromatography/mass spectrometry and on-the-fly orthogonal array optimization for quantification of therapeutic monoclonal antibodies and the application in preclinical analysis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Nano-scale liquid chromatograp ...... ation in preclinical analysis.
@en
Nano-scale liquid chromatograp ...... ation in preclinical analysis.
@nl
type
label
Nano-scale liquid chromatograp ...... ation in preclinical analysis.
@en
Nano-scale liquid chromatograp ...... ation in preclinical analysis.
@nl
prefLabel
Nano-scale liquid chromatograp ...... ation in preclinical analysis.
@en
Nano-scale liquid chromatograp ...... ation in preclinical analysis.
@nl
P2093
P2860
P1476
Nano-scale liquid chromatograp ...... ation in preclinical analysis.
@en
P2093
Joseph P Balthasar
Lipeng Dai
Shang-Chiung Chen
Xiaotao Duan
P2860
P356
10.1016/J.CHROMA.2012.06.007
P407
P577
2012-06-21T00:00:00Z